Intercept Pharmaceuticals (ICPT) PT Raised to $175 at Oppenheimer; 'REGENERATE Top Line Sparks Joy'

February 19, 2019 1:03 PM
Oppenheimer analyst Jay Olson raised the price target on Intercept Pharmaceuticals (NASDAQ: ICPT) to $175.00 (from $140.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)


Analyst Comments Analyst PT Change

Next Articles